Pharmaceutical firms rake in billions with Covid jabs
Some of the world's largest pharmaceutical companies have released their latest financial results which show how the Covid vaccines have added billions to their coffers
Covid-19: How vaccines work against the Delta variant
The Delta variant of the coronavirus, first identified in India, is a cause for global concern with studies showing it is more contagious and resistant to vaccines than other forms of Covid
EMA chief urges worldwide vaccine access, after G7 vow
The head of the European Medicines Agency told AFP that all countries must have access to coronavirus vaccines, as G7 leaders pledged one billion doses for poor nations
G7’s billion jabs plan highlights global imbalance
The G7's plan to donate one billion Covid-19 vaccine doses will help combat the pandemic in poorer countries but will hardly end the drastic global imbalance in access to jabs
EU asks for big penalties against AstraZeneca over dose delays
The European Union has asked a Belgian court to impose penalties running to millions of euros per day on AstraZeneca for Covid-19 vaccine doses it has failed to deliver to the bloc
The European Covid certificate, a user’s guide
The EU will launch its digital Covid certificate on July 1. How will it use data on vaccinations, tests and immunity to usher in a return to summer tourism and travel across the European Union?
Clot questions over J&J and AstraZeneca vaccines
The European Medicines Agency (EMA) says blood clots should be listed as a "very rare" side effect of the Johnson & Johnson COVID vaccine. What we know about the jab and similar AstraZeneca shot:
AstraZeneca vaccine: what we know and what we don’t
A European Medicines Agency recommendation that a type of blood clot should be listed as a "very rare side effect" of the AstraZeneca jab stopped just short of saying there is a causal link with the vaccine
AstraZeneca: Who is using the jab, and who isn’t
The AstraZeneca vaccine's rollercoaster ride has taken another twist with a growing list of countries restricting its use over "very rare" blood clots
Questions about AstraZeneca jab linger
Fears of what is causing the 'highly untypical' blood clots seen in some people vaccinated against Covid-19 have undermined confidence in the AstraZeneca vaccine